Apremilast, Darreichungsform: FTA(ATC-Code: L04AA32)

TENDER DESCRIPTION

This publication serves to conclude agreements on the active ingredient "Apremilast, dosage form: FTA (ATC code: L04AA32)" with pharmaceutical companies within the meaning of § 130a paragraph 8 sentence 1 of the Social Code, Book Five (SGB V) (discount agreements). According to § 130a paragraph 8 sentence 1 SGB V, the invitation to participate is addressed only to pharmaceutical entrepreneurs or employee communities of pharmaceutical entrepreneurs within the meaning of § 4 paragraph 18 of the Medicines Act (AMG). This is not an open procedure, but a publication of the invitation to conclude/join discount agreements with conditions fixed and non-negotiable for all participants, including the amount of the discount. The corresponding information under item 2.1 "procedure type" and item 5.1.12 "condition for award_here: deadline until which the offer must be valid" is due only to the systematics of this template. Contract partners can be an unlimited number of pharmaceutical entrepreneurs or employee communities of pharmaceutical entrepreneurs within the meaning of § 4 paragraph 18 of the Medicines Act (AMG). The contract conclusion or joining takes place by sending the required…

TENDER BRIEF

TENDER DOCUMENTS